First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cellsMohammad Hojjat‐Farsangi, Ali Moshfegh, Fariba Mozaffari et al.|Leukemia|2018Cited by 52
First generation of a small chemical molecule ROR1 RTK tyrosine kinase inhibitorHåkan Mellstedt, Anders Österborg, Mohammad Hojjat‐Farsangi et al.|Annals of Oncology|2016Cited by 3